Literature DB >> 15606117

Glyoxylic acid and MP-glyoxylate: efficient formaldehyde equivalents in the 3-CC of 2-aminoazines, aldehydes, and isonitriles.

Michael A Lyon1, Timothy S Kercher.   

Abstract

[reaction: see text] Glyoxylic acid, either in solution or immobilized on MP-carbonate (MP-glyoxylate), participates in an uncatalyzed 3-CC with 2-aminoazines and isonitriles to afford novel 2-unsubstituted-3-amino-imidazoheterocycles. MP-glyoxylate serves as a particularly efficient and experimentally convenient formaldehyde equivalent and readily liberates products through decarboxylation/self-release from the resin. These examples furthermore constitute the first application in which MP-CO3 serves as a solid support for transformations involving carboxylic acids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606117     DOI: 10.1021/ol0478234

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

Review 1.  Emerging approaches for the syntheses of bicyclic imidazo[1,2-x]-heterocycles.

Authors:  Christopher Hulme; Yeon-Sun Lee
Journal:  Mol Divers       Date:  2008-04-12       Impact factor: 2.943

2.  General and efficient copper-catalyzed three-component coupling reaction towards imidazoheterocycles: one-pot synthesis of alpidem and zolpidem.

Authors:  Natalia Chernyak; Vladimir Gevorgyan
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-01       Impact factor: 15.336

Review 3.  Groebke-Blackburn-Bienaymé multicomponent reaction: emerging chemistry for drug discovery.

Authors:  Saad Shaaban; Bakr F Abdel-Wahab
Journal:  Mol Divers       Date:  2015-05-28       Impact factor: 2.943

4.  Overcoming co-product inhibition in the nicotinamide independent asymmetric bioreduction of activated C=C-bonds using flavin-dependent ene-reductases.

Authors:  Christoph K Winkler; Dorina Clay; Esta van Heerden; Kurt Faber
Journal:  Biotechnol Bioeng       Date:  2013-07-10       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.